Skip to main content

Table 2 Flea count data for each treatment group and statistical analysis of flea count reduction from baseline for each treatment group

From: A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA

Flea count data

Lotilaner treatment group

Fipronil and S-methoprene treatment group

Day 0 (pre-treatment)

 Arithmetic mean ± SD

46.3 ± 61.0

45.3 ± 59.5

 Rangea

5–251

5–251

 Geometric mean

24.6

25.8

Day 30

 Arithmetic mean ± SD

1.3 ± 5.1

27.3 ± 52.0

 Range

0–48

0–251

 Geometric mean

0.4

9.9

 % Efficacyb

98.3

61.6

 Statistical analysis

t(114) = 29.05, P < 0.0001

t(61) = 6.86, P < 0.0001

Day 60

 Arithmetic mean ± SD

0.0 ± 0.2

17.6 ± 36.0

 Range

0–1

0–184

 Geometric mean

0.0

6.3

 % Efficacyb

99.9

75.4

 Statistical analysis

t(203) = 32.65, P < 0.0001

t(59) = 8.86, P < 0.0001

Day 90

 Arithmetic mean ± SD

0.1 ± 0.6

9.0 ± 12.0

 Range

0–6

0–59

 Geometric mean

0.0

4.0

 % Efficacyb

99.9

84.7

 Statistical analysis

t(221) = 32.94, P < 0.0001

t(51) = 9.63, P < 0.0001

  1. aRange: any count > 250 fleas was assigned the value 251
  2. b% Efficacy: based on geometric means